From diagnosis methods to management of comorbid infections, new lung cancer protocols adaptable for various conditions ...

Researchers engineered a nanobody-conjugated liposome (A5-LNP-DOX) that targets CD155 and delivers doxorubicin directly to lung adenocarcinoma cells, dramatically suppressing tumor growth in ...

Nicole A. Cipriani, MD, offers guidance for community oncologists regarding the role of BRAF p.V600E testing in patients with papillary thyroid carcinoma.

ORLANDO — For low-risk patients with papillary thyroid carcinoma interested in something other than surgery or surveillance, radiofrequency ablation may be an option, according to a speaker. At ...

Pleural effusion metastatic papillary thyroid carcinoma with dedifferentiation is a rare clinical presentation. We present the case of a 78-year-old female patient who developed chest tightness, ...

Lung Squamous cell carcinoma (LSCC) represents the second most common non-small cell lung cancer. Although studies identified adenocarcinoma-like driver mutations in LSCC using next-generation ...

Urothelial carcinoma, or transitional cell carcinoma, is the most common bladder cancer and grows in the urothelial cells lining the urinary tract.

New research delves into the DNA details and chromatin structures that may predict prognosis in early-stage lung adenocarcinoma.

MAP17 influences the regulation of the AKT signaling pathway in papillary thyroid carcinoma, impacting critical cellular processes associated with PTC progression. Gaining a deeper understanding of ...

Ureteral papillary carcinoma is a rare subtype of urothelial carcinoma, ranking fourth among cancers following prostate (or breast) cancer, lung cancer, and colorectal cancer. Although previous ...